Recommendation ID
NICE recommends that a new model for multiple sclerosis is developed, ideally based on UK patient cohorts, which uses the best available evidence (including experience to date from the risk-sharing scheme) and includes all currently available treatments.
Any explanatory notes
(if applicable)

Source guidance details

Comes from guidance
Fingolimod for the treatment of highly active relapsing–remitting multiple sclerosis
Date issued
April 2012

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No